Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets

The findings of this study elucidate a mechanistic relationship among diabetes, inflammation, oxidative stress, and PQC impairment in the context of HFpEF. Therapeutic strategies that target these dysregulated pathways, including IL-6 inhibition, mitochondrial antioxidants, and chaperone-mediated protection, may enhance myocardial function in HFpEF patients with T2DM. Addressing these molecular dysfunctions could facilitate the development of novel interventions specifically tailored to the diabetic HFpEF population.

Authors

Institutions

Publication Details

Journal
Cardiovascular Diabetology
Published
2025-05-14
DOI
https://doi.org/10.1186/s12933-025-02734-4
Citations
24
Primary Topic
Cardiovascular Function and Risk Factors
Type
article
Field-Weighted Citation Impact
33.32

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets

Nazha Hamdani, Árṕad Kov́acs, Innas Sultana, Marcel Sieme et al.
24 citations
Cardiovascular Diabetology
Cardiovascular Function and Risk Factors
33.32
article

Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets

Nazha Hamdani, Árṕad Kov́acs, Innas Sultana, Marcel Sieme, Loek van Heerebeek, Wiebke Fenske, Heidi Budde, Péter Ferdinandy, Domokos Máthé, Kornélia Jaquet, Andreas Mügge, Peter Haldenwang, Mustafa Kaçmaz, Jan Wintrich, Saltanat Zhazykbayeva, Zoltán V. Varga, Melissa Herwig, Benjamin Sasko, Simin Delalat, Viktória É. Tóth, Muchtiar Khan, Wolfgang E. Schmidt, Hersh Osman, Ibrahim El-Battrawy, Eda Göztepe, Natalie Borgmann, Gelareh Shahriari
article en
24 citations

Abstract

The findings of this study elucidate a mechanistic relationship among diabetes, inflammation, oxidative stress, and PQC impairment in the context of HFpEF. Therapeutic strategies that target these dysregulated pathways, including IL-6 inhibition, mitochondrial antioxidants, and chaperone-mediated protection, may enhance myocardial function in HFpEF patients with T2DM. Addressing these molecular dysfunctions could facilitate the development of novel interventions specifically tailored to the diabetic HFpEF population.

Cardiovascular DiabetologyVol. 24(1)
Semmelweis University (HU), University of Debrecen (HU), University Hospitals of the Ruhr-University of Bochum (DE), Universitätsklinik Marien Hospital Herne (DE), OLVG (NL), Centre for Social Sciences (HU), St. Josef-Hospital (DE), BG University Hospital Bergmannsheil Bochum (DE), Ruhr University Bochum (DE)
Ruhr-Universität Bochum
Good health and well-being
Openalex Percentile: Top 0%
Cardiovascular Function and Risk Factors
33.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.